Omnicell, Inc.
Omnicell provides medication management solutions and adherence tools for healthcare systems and pharmacies worldwide. They offer point-of-care automation, automated dispensing systems, robotic dispensing, central pharmacy automation, IV compounding robots, and inventory management software. The company also provides single-dose automation, filling equipment, packaging supplies, and EnlivenHealth Patient Engagement web-based solutions.
Overview
Sector
Health Information Services
Strengths
- High-quality earnings: over the last 6 years, free cash flow added up to 593% of reported net income.
- Cheaper than its own history: P/FCF 24.7x vs. a historical average of 69.4x.
Weaknesses
- Our discounted cash flow model finds no value to support the current price: projected cash flows do not cover its debt and current valuation.
- Unstable profitability: operating margin ranged from -3% to 8% over the last 6 years, with operating losses in 2 of them.
- Valued at a premium to its Health Information Services peers: P/FCF 24.7x vs. a median of 17.2x and EV/EBITDA 18.7x vs. a median of 11.4x.
- Earnings are projected to decline (-10.0% per year).
Key Financial Data